Cancer research is big business, and it pays to know where research dollars are headed.
Novartis (NYSE:NVS) has been reiterated by TheStreet Ratings as a buy with a ratings score of A
TheStreet Ratings group highlights 3 stocks pushing the drugs industry lower today.
Synageva BioPharma Corp. announced that it has received breakthrough therapy designation from the US Food and Drug Administration for sebelipase alfa.
Is There Growth Left in Massive Drug Stocks?
Biogen submits Plegridy for FDA approval.